0001546927-15-000261.txt : 20151020 0001546927-15-000261.hdr.sgml : 20151020 20151020135022 ACCESSION NUMBER: 0001546927-15-000261 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151015 FILED AS OF DATE: 20151020 DATE AS OF CHANGE: 20151020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 BUSINESS PHONE: 972-4-988-9488 MAIL ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Camber Capital Management LLC CENTRAL INDEX KEY: 0001444043 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33357 FILM NUMBER: 151166044 BUSINESS ADDRESS: STREET 1: 101 HUNTINGTON AVENUE STREET 2: SUITE 2550 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-717-6600 MAIL ADDRESS: STREET 1: 101 HUNTINGTON AVENUE STREET 2: SUITE 2550 CITY: BOSTON STATE: MA ZIP: 02199 3 1 camberprotalxform3filed.xml OWNERSHIP DOCUMENT X0206 3 2015-10-15 0 0001006281 Protalix BioTherapeutics, Inc. PLX 0001444043 Camber Capital Management LLC 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 0 0 1 0 Common Stock 9274577 I See Footnotes Convertible Note Contracts 1562933 I See Footnotes Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock and Convertible Note Contracts (on an as-coverted basis) beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 25, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. Of the securities reported herein, 8,953,095 shares of Common Stock are held for the account of the Master Fund, 63,057 shares of Common Stock are held for the account of the Fund, and 258,425 shares of Common Stock are held for the account of the Managed Account. Of the securities reported herein, 8,541 Convertible Note Contracts (equivalent to 1,483,224 shares of Common Stock on an as-coverted basis) are held for the account of the Master Fund, 68 Convertible Note Contracts (equivalent to 11,878 shares of Common Stock on an as-coverted basis) are held for the account of the Fund, and 391 Convertible Note Contracts (equivalent to 67,831 shares of Common Stock on an as-coverted basis) are held for the account of the Managed Account. Stephen DuBois 2015-10-20